カテゴリ： 世界, 医療/バイオ, QYResearch

PIG豚繁殖呼吸器症候群（PRRS）ワクチンの世界市場2023年：CH-1R株、PC株、その他

■ 英語タイトル：Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA3022）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA3022
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[PIG豚繁殖呼吸器症候群（PRRS）ワクチンの世界市場2023年：CH-1R株、PC株、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はPIG豚繁殖呼吸器症候群（PRRS）ワクチンのグローバル市場について調査・分析し、世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（CH-1R株、PC株、その他）、用途別セグメント分析（雌豚、雌豚）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Merck、HIPRA、Sinopharm Animal Health Co., Ltd、Ceva Santé Animale、CAVAC、Bioveta、Jinyu Bio-Technology、Zoetis、Boehringer Ingelheim、Harbin Pharmaceutical Groupなどが含まれています。PIG豚繁殖呼吸器症候群（PRRS）ワクチンのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、PIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模を算出する際に考慮しました。

・PIG豚繁殖呼吸器症候群（PRRS）ワクチン市場の概要
- 製品の定義
- PIG豚繁殖呼吸器症候群（PRRS）ワクチンの種類別セグメント
- 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模：タイプ別分析（CH-1R株、PC株、その他）
- PIG豚繁殖呼吸器症候群（PRRS）ワクチンの用途別セグメント
- 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模：用途別分析（雌豚、雌豚）
- 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模予測（2018年-2029年）
- PIG豚繁殖呼吸器症候群（PRRS）ワクチンの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- PIG豚繁殖呼吸器症候群（PRRS）ワクチン市場の競争状況およびトレンド

・PIG豚繁殖呼吸器症候群（PRRS）ワクチンの地域別市場規模
- 北米のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年）
- 米国のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年）
- ヨーロッパのPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年）
- アジア太平洋のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年）
- 中国のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年）
- 日本のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年）
- 韓国のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年）
- インドのPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年）
- オーストラリアのPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年）
- 中南米のPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年）
- 中東・アフリカのPIG豚繁殖呼吸器症候群（PRRS）ワクチン市場規模（2018年-2029年）

・種類別セグメント：CH-1R株、PC株、その他
- 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチンのタイプ別販売量（2018年-2023年）
- 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチンのタイプ別売上（2018年-2023年）
- 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチンのタイプ別価格

・用途別セグメント：雌豚、雌豚
- 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチンの用途別販売量（2018年-2023年）
- 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチンの用途別売上（2018年-2023年）
- 世界のPIG豚繁殖呼吸器症候群（PRRS）ワクチンの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Merck、HIPRA、Sinopharm Animal Health Co., Ltd、Ceva Santé Animale、CAVAC、Bioveta、Jinyu Bio-Technology、Zoetis、Boehringer Ingelheim、Harbin Pharmaceutical Group

・産業チェーンと販売チャネルの分析
- PIG豚繁殖呼吸器症候群（PRRS）ワクチン産業チェーン分析
- PIG豚繁殖呼吸器症候群（PRRS）ワクチンの主要原材料
- PIG豚繁殖呼吸器症候群（PRRS）ワクチンの販売チャネル
- PIG豚繁殖呼吸器症候群（PRRS）ワクチンのディストリビューター
- PIG豚繁殖呼吸器症候群（PRRS）ワクチンの主要顧客

・PIG豚繁殖呼吸器症候群（PRRS）ワクチン市場ダイナミクス
- PIG豚繁殖呼吸器症候群（PRRS）ワクチンの業界動向
- PIG豚繁殖呼吸器症候群（PRRS）ワクチン市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine include Merck, HIPRA, Sinopharm Animal Health Co., Ltd, Ceva Santé Animale, CAVAC, Bioveta, Jinyu Bio-Technology, Zoetis and Boehringer Ingelheim, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.
The PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Merck
HIPRA
Sinopharm Animal Health Co., Ltd
Ceva Santé Animale
CAVAC
Bioveta
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim
Harbin Pharmaceutical Group
Segment by Type
CH-1R Strain
PC Strain
Others
Segment by Application
Gilts
Sows
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Overview
1.1 Product Overview and Scope of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
1.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type
1.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 CH-1R Strain
1.2.3 PC Strain
1.2.4 Others
1.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application
1.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value by Application: (2023-2029)
1.3.2 Gilts
1.3.3 Sows
1.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Estimates and Forecasts
1.4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue 2018-2029
1.4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales 2018-2029
1.4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competition by Manufacturers
2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Product Type & Application
2.7 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competitive Situation and Trends
2.7.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue
2.7.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Retrospective Market Scenario by Region
3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2018-2029
3.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2018-2023
3.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2024-2029
3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2018-2029
3.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2018-2023
3.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2024-2029
3.4 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.4.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.4.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.5.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.5.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.7.1 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.7.3 Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2018-2029)
4.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2018-2023)
4.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2024-2029)
4.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2018-2029)
4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2018-2029)
4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2018-2023)
4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2024-2029)
4.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2018-2029)
5.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2018-2023)
5.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2024-2029)
5.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2018-2029)
5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2018-2029)
5.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2018-2023)
5.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2024-2029)
5.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 HIPRA
6.2.1 HIPRA Corporation Information
6.2.2 HIPRA Description and Business Overview
6.2.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.2.5 HIPRA Recent Developments/Updates
6.3 Sinopharm Animal Health Co., Ltd
6.3.1 Sinopharm Animal Health Co., Ltd Corporation Information
6.3.2 Sinopharm Animal Health Co., Ltd Description and Business Overview
6.3.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.3.5 Sinopharm Animal Health Co., Ltd Recent Developments/Updates
6.4 Ceva Santé Animale
6.4.1 Ceva Santé Animale Corporation Information
6.4.2 Ceva Santé Animale Description and Business Overview
6.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.4.5 Ceva Santé Animale Recent Developments/Updates
6.5 CAVAC
6.5.1 CAVAC Corporation Information
6.5.2 CAVAC Description and Business Overview
6.5.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.5.5 CAVAC Recent Developments/Updates
6.6 Bioveta
6.6.1 Bioveta Corporation Information
6.6.2 Bioveta Description and Business Overview
6.6.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.6.5 Bioveta Recent Developments/Updates
6.7 Jinyu Bio-Technology
6.6.1 Jinyu Bio-Technology Corporation Information
6.6.2 Jinyu Bio-Technology Description and Business Overview
6.6.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.7.5 Jinyu Bio-Technology Recent Developments/Updates
6.8 Zoetis
6.8.1 Zoetis Corporation Information
6.8.2 Zoetis Description and Business Overview
6.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.8.5 Zoetis Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Harbin Pharmaceutical Group
6.10.1 Harbin Pharmaceutical Group Corporation Information
6.10.2 Harbin Pharmaceutical Group Description and Business Overview
6.10.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
6.10.5 Harbin Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Chain Analysis
7.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process
7.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Marketing
7.4.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels
7.4.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
7.5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
8 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Dynamics
8.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
8.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
8.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Challenges
8.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. HIPRA Corporation Information
Table 76. HIPRA Description and Business Overview
Table 77. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 79. HIPRA Recent Developments/Updates
Table 80. Sinopharm Animal Health Co., Ltd Corporation Information
Table 81. Sinopharm Animal Health Co., Ltd Description and Business Overview
Table 82. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 84. Sinopharm Animal Health Co., Ltd Recent Developments/Updates
Table 85. Ceva Santé Animale Corporation Information
Table 86. Ceva Santé Animale Description and Business Overview
Table 87. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 89. Ceva Santé Animale Recent Developments/Updates
Table 90. CAVAC Corporation Information
Table 91. CAVAC Description and Business Overview
Table 92. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 94. CAVAC Recent Developments/Updates
Table 95. Bioveta Corporation Information
Table 96. Bioveta Description and Business Overview
Table 97. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 99. Bioveta Recent Developments/Updates
Table 100. Jinyu Bio-Technology Corporation Information
Table 101. Jinyu Bio-Technology Description and Business Overview
Table 102. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 104. Jinyu Bio-Technology Recent Developments/Updates
Table 105. Zoetis Corporation Information
Table 106. Zoetis Description and Business Overview
Table 107. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 109. Zoetis Recent Developments/Updates
Table 110. Boehringer Ingelheim Corporation Information
Table 111. Boehringer Ingelheim Description and Business Overview
Table 112. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 114. Boehringer Ingelheim Recent Developments/Updates
Table 115. Harbin Pharmaceutical Group Corporation Information
Table 116. Harbin Pharmaceutical Group Description and Business Overview
Table 117. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product
Table 119. Harbin Pharmaceutical Group Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List
Table 123. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers List
Table 124. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Trends
Table 125. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Drivers
Table 126. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Challenges
Table 127. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine
Figure 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Type in 2022 & 2029
Figure 4. CH-1R Strain Product Picture
Figure 5. PC Strain Product Picture
Figure 6. Others Product Picture
Figure 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Application in 2022 & 2029
Figure 9. Gilts
Figure 10. Sows
Figure 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (2018-2029) & (US$ Million)
Figure 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2018-2029) & (K Units)
Figure 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 15. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Report Years Considered
Figure 16. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players: Market Share by Revenue in 2022
Figure 19. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2018-2029)
Figure 22. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2018-2029)
Figure 23. United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2018-2029)
Figure 26. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2018-2029)
Figure 27. Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2018-2029)
Figure 34. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2018-2029)
Figure 44. Latin America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2018-2029)
Figure 45. Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2018-2029)
Figure 50. Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Type (2018-2029)
Figure 54. Global Revenue Market Share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Type (2018-2029)
Figure 55. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Application (2018-2029)
Figure 57. Global Revenue Market Share of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Application (2018-2029)
Figure 58. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 59. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain
Figure 60. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • PIG豚繁殖呼吸器症候群（PRRS）ワクチンのグローバル市場展望 2023年-2029年：CH-1R株、PC株、その他
  • 豚サーコウイルスワクチンのグローバル市場展望 2023年-2029年：遺伝子組み換えワクチン、死菌ワクチン
  • 生殖補助医療機器の世界市場2023年：カテーテル、ディッシュ、メディア、吸引針、ピペット
  • 月経前症候群治療薬のグローバル市場展望 2023年-2029年：PH-80PMD、エストロゲン、プロゲステロン、その他
  • 注意欠陥・多動性症候群治療の世界市場2023年：精神刺激薬、非精神刺激薬
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA3022 )"PIG豚繁殖呼吸器症候群（PRRS）ワクチンの世界市場2023年：CH-1R株、PC株、その他" (英文：Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。